newsfilter
← Latest News
Business Wire·

Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference

Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Credit